Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2280]
News [5219]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
The 1st Immunotherapy of Cancer Conference (ITOC)
Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria
The 1st Immunotherapy of Cancer Conference (ITOC) ( Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria )
25 Mar 2014
Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer
Dr Christian Klein - Head of Oncology Programs, Discovery Oncology, Roche...
Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer ( Dr Christian Klein - Head of Oncology Programs, Discovery Oncology, Roche Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland )
24 Mar 2014
Mechanisms of action and robotics in mCRPC
Dr Anthony Ng Chi-Fai - University of Hong Kong, Hong Kong, China
Mechanisms of action and robotics in mCRPC ( Dr Anthony Ng Chi-Fai - University of Hong Kong, Hong Kong, China )
21 Mar 2014
mCRPC management in Taiwan - expert interview
Prof Paul de Souza and Dr Wayne Yen-Hwa Chang
mCRPC management in Taiwan - expert interview ( Prof Paul de Souza and Dr Wayne Yen-Hwa Chang )
21 Mar 2014
Cost constraints affect treatment decision-making in China and Singapore...
Prof Kurt Miller, Dr Li-qun Zhou and Dr Ravindran Kanesvaran
Cost constraints affect treatment decision-making in China and Singapore - expert discussion ( Prof Kurt Miller, Dr Li-qun Zhou and Dr Ravindran Kanesvaran )
21 Mar 2014
Insights into mCRPC in China, Thailand and Indonesia - expert discussion
Prof Rainy Umbas, Prof Narin Voravud and Prof Li Ping Xie
Insights into mCRPC in China, Thailand and Indonesia - expert discussion ( Prof Rainy Umbas, Prof Narin Voravud and Prof Li Ping Xie )
21 Mar 2014
The future of mCRPC treatment - expert discussion
Prof Li Ping Xie - Zhejiang University School of Medicine, Hangzhou, China and...
The future of mCRPC treatment - expert discussion ( Prof Li Ping Xie - Zhejiang University School of Medicine, Hangzhou, China and Prof Paul de Souza - University of Western Sydney, Sydney, Australia )
21 Mar 2014
Sharing Indian perspectives on CRPC
Dr Senthil Rajippa - Kidwai Memorial Institute of Oncology, Bangalore, India
Sharing Indian perspectives on CRPC ( Dr Senthil Rajippa - Kidwai Memorial Institute of Oncology, Bangalore, India )
21 Mar 2014
ecancermedicalscience Editor's Choice for January 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for January 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
12 Feb 2014
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma
Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios...
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma ( Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios Dimopoulos )
2 Feb 2014
Critical insights on leukaemia and lymphoma from ASH 2013
Prof Robin Foa, Dr Simon Rule, Dr Clemens Wendtner
Critical insights on leukaemia and lymphoma from ASH 2013 ( Prof Robin Foa, Dr Simon Rule, Dr Clemens Wendtner )
2 Feb 2014
Latest treatment for CRPC: Combinations, sequencing, radiotherapy and...
Dr Maria De Santis - Kaiser Franz Josef Hospital, Vienna, Austria
Latest treatment for CRPC: Combinations, sequencing, radiotherapy and immunotherapy ( Dr Maria De Santis - Kaiser Franz Josef Hospital, Vienna, Austria )
31 Jan 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation